| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 03/11/2004 | CA2497086A1 Method of controlling pharmacokinetics of immunomodulatory compounds |
| 03/11/2004 | CA2497045A1 Pharmaceutical liposomal compositions containing n. meningitidis derived polypeptides or polynucleotides |
| 03/11/2004 | CA2496948A1 Il-14 vaccine for the treatment of asthma and atopic disorders |
| 03/11/2004 | CA2496885A1 Method of diagnosing colon and gastric cancers |
| 03/11/2004 | CA2496795A1 Compositions and methods for treating cardiovascular disease |
| 03/11/2004 | CA2496769A1 Buccal, polar and non-polar spray or capsule containing cardiovascular or renal drugs |
| 03/11/2004 | CA2496607A1 Vaccine comprising il-13 and an adjuvant |
| 03/11/2004 | CA2496547A1 Use of apoptosis inducing agents in the preparation of a medicament for the treatment of liver diseases |
| 03/11/2004 | CA2496409A1 Immunogenic composition comprising an il-13 element and t cell epitopes, and its therapeutic use |
| 03/11/2004 | CA2496045A1 Method for refolding neisserial nspa protein |
| 03/11/2004 | CA2495295A1 Group b streptococcal phage lysin |
| 03/11/2004 | CA2495207A1 Modified transferin-antibody fusion proteins |
| 03/11/2004 | CA2495086A1 Mutant protein and refolding method |
| 03/11/2004 | CA2494772A1 Circular nucleic acid vectors, and methods for making and using the same |
| 03/11/2004 | CA2491568A1 Use of escherichia coli heat labile toxin as an adjuvant in birds and poultry |
| 03/11/2004 | CA2402685A1 Renal cell carcinoma-antigen g250-derived peptides that elicit both cd4+ and cd8+ t-cell |
| 03/10/2004 | EP1396547A1 Arachidonic acid metabolites and modulation of mitosis and apoptosis of cells |
| 03/10/2004 | EP1396546A2 mycobacteria functional screening and/or expression vectors |
| 03/10/2004 | EP1396542A2 Novel P-selectin ligand protein |
| 03/10/2004 | EP1395829A2 Cancer associated protein |
| 03/10/2004 | EP1395684A2 New polynucleotides and polypeptides of the ifnalpha-7 gene |
| 03/10/2004 | EP1395609A2 Hypoxia inducible factors and uses thereof for inducing angiogenesis and improving muscular functions |
| 03/10/2004 | EP1395605A2 Polymeric immunoglobulin fusion proteins that target low-affinity fcgamma receptors |
| 03/10/2004 | EP1395290A2 Cytotoxic cd44 antibody immunoconjugates |
| 03/10/2004 | EP1395285A2 Reagents and methods for modulating dkk-mediated interactions |
| 03/10/2004 | EP1395284A2 Cd4-specific antibody trx1 and uses therefor |
| 03/10/2004 | EP1395283A2 Heterologous protection induced by immunization with invaplex vaccine |
| 03/10/2004 | EP1395282A1 Vaccine complex for preventing or treating leishmaniases |
| 03/10/2004 | EP1395281A1 Recombinant mhc molecules useful for manipulation of antigen-specific t-cells |
| 03/10/2004 | EP1395275A2 Beta-secretase substrates and uses thereof |
| 03/10/2004 | EP1395274A2 Compositions and methods for inhibiting metastasis |
| 03/10/2004 | EP1395262A2 Nucleoside vaccine adjuvants |
| 03/10/2004 | EP1395256A2 Prodrugs via acylation with cinnamate |
| 03/10/2004 | EP0885011B1 Diagnosis of autoimmune diseases of the inner ear based on the detection of myelin protein p zero |
| 03/10/2004 | EP0868198B1 FCepsilon-PE CHIMERIC PROTEIN FOR TARGETED TREATMENT OF ALLERGY RESPONSES, A METHOD FOR ITS PRODUCTION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME |
| 03/10/2004 | EP0854729B1 Improved methods for the production of non-covalently complexed and multivalent proteosome sub-unit vaccines |
| 03/10/2004 | EP0769955B1 Non-antigenic amine derived polymers and polymer conjugates |
| 03/10/2004 | EP0762894B1 Method of inducing an immune response with a live venezuelan equine encephalitis virus expressing a heterologous immunogen |
| 03/10/2004 | EP0651653B1 p53 VACCINE |
| 03/10/2004 | CN1481390A Immunomodulatory peptidesderived from heat shock proteins and uses thereof |
| 03/10/2004 | CN1481255A Vaccines |
| 03/10/2004 | CN1481254A Adjuvant compsn comprising immunostimulatory oligonucleotide and tocol |
| 03/10/2004 | CN1480534A Shuttle vector of repeatable adenovirus of targeting melanoma and adenovirus |
| 03/10/2004 | CN1480463A Chirality peptide antigen and compon of bacterin based on core sequence of mucin 1 |
| 03/10/2004 | CN1480215A Compound antibody vaccine of SARS virus antigen as well as its model of experimental animal and method |
| 03/10/2004 | CN1480214A Vaccinum contg saponin and sterol |
| 03/10/2004 | CN1141143C Application of ginseng total saponin RbI vaccine immunological adjuvant |
| 03/10/2004 | CN1141142C Genetically engineered vaccine of MUC-1 antigen for human breast cancer |
| 03/09/2004 | US6703494 Thrombosis, adult respiratory system disorders |
| 03/09/2004 | US6703381 Administering amphiphilic enkephalin-oligomer conjugate |
| 03/09/2004 | US6703361 Method of treating or preventing Type 1 diabetes by oral administration of insulin |
| 03/09/2004 | US6703238 Methods for expanding antigen-specific T cells |
| 03/09/2004 | US6703233 Used for stabilizing expression plasmids for use in a genetic vaccine; removes sole dependence on catalytic balanced lethal maintenance system, incorporates a plasmid partition system preventing random segregation of plasmids |
| 03/09/2004 | US6703231 gM-negative EHV-mutants |
| 03/09/2004 | US6703025 Multicomponent vaccines |
| 03/09/2004 | US6703024 Having specified amino acid sequence |
| 03/09/2004 | US6703023 Circovirus sequences associated with piglet weight loss disease (PWD) |
| 03/09/2004 | US6703021 Composition containing α-fodrin or α-fodrin fragment protein |
| 03/09/2004 | US6703020 Antibody conjugate methods for selectively inhibiting VEGF |
| 03/09/2004 | US6703018 Method of treatment using humanized anti-CD11a antibodies |
| 03/09/2004 | US6703016 Apoptotic bodies, monocyte derived cells containing the same, a process for their preparation and their uses as vaccines |
| 03/09/2004 | US6703015 Vaccination against plaque forming diseases, alzheimer's disease |
| 03/09/2004 | CA2323929C Methods and products for stimulating the immune system using immunotherapeutic oligonucleotides and cytokines |
| 03/04/2004 | WO2004018999A2 Compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer |
| 03/04/2004 | WO2004018698A2 Lectin compositions and methods for modulating an immune response to an antigen |
| 03/04/2004 | WO2004018684A2 T-cell epitopes in staphylococcal enterotoxin b |
| 03/04/2004 | WO2004018683A1 Streptococcus uberis protein, nucleic acid sequence encoding the same and its use in a mastitis vaccine |
| 03/04/2004 | WO2004018681A2 Il-7 drug substance, il- 7 comprising composition, preparation and uses thereof |
| 03/04/2004 | WO2004018680A1 Method of screening tumor antigen |
| 03/04/2004 | WO2004018666A1 Expression vectors encoding epitopes of target-associated antigens |
| 03/04/2004 | WO2004018659A1 Process for the production of temperature-induced tumor cell lysates for use as immunogenic compounds |
| 03/04/2004 | WO2004018648A2 Methods for treating patients and identifying therapeutics |
| 03/04/2004 | WO2004018646A2 Conserved and specific streptococcal genomes |
| 03/04/2004 | WO2004018635A2 Myxococcus xanthus bacteriophage mx9 transformation and integration system |
| 03/04/2004 | WO2004018630A2 Recombinant double-stranded rna phages and uses thereof |
| 03/04/2004 | WO2004018627A2 Methods for propagating adenovirus and virus produced thereby |
| 03/04/2004 | WO2004018519A2 Therapeutic uses of monoclonal antibodies to the angiotensin-ii type-1 receptor |
| 03/04/2004 | WO2004018514A1 Polypeptides of nontypeable haemophilus influenzae and corresponding dna fragments |
| 03/04/2004 | WO2004018507A1 Compositions and methods for treatment and prophylaxis of infections caused by gram positive bacteria |
| 03/04/2004 | WO2004018043A1 A pharmaceutical preparation containing palladium complex compounds and the uses thereof for treating cancer and autoimmune disease |
| 03/04/2004 | WO2004018000A2 Compositions and methods for treating cancer using maytansinoid cd44 antibody immonoconjugates and chemotherapeutic agents |
| 03/04/2004 | WO2004017992A2 Ptk7 protein involvement in carcinoma |
| 03/04/2004 | WO2004017990A1 Vaccine for respiratory and reproductive system infections in cattle |
| 03/04/2004 | WO2004017923A2 Compositions and methods of therapy for cancers characterized by expression of the tumor-associated antigen mn/ca ix |
| 03/04/2004 | WO2004017909A2 Methods of reducing ischemic injury |
| 03/04/2004 | WO2004017810A2 Tumor specific oligosaccharide epitopes and use thereof |
| 03/04/2004 | WO2004017727A1 A method of treatment and prophylaxis |
| 03/04/2004 | WO2004007538A3 Molecular antigen arrays using a virus like particle derived from the ap205 coat protein |
| 03/04/2004 | WO2003101173A3 Immunomodulatory constructs and their uses |
| 03/04/2004 | WO2003097091A3 Glucan-based vaccines |
| 03/04/2004 | WO2003094960A3 Mucosal combination vaccines for bacterial meningitis |
| 03/04/2004 | WO2003082327A3 Combined dna/protein vaccine compositions |
| 03/04/2004 | WO2003080104A3 Use of il-18 inhibitors for the treatment and/or prevention of peripheral vascular diseases |
| 03/04/2004 | WO2003074555A3 Synthetic peptides from c. difficile |
| 03/04/2004 | WO2003070760A3 Anti-amyloid beta antibodies and their use |
| 03/04/2004 | WO2003068822A3 De-immunized (poly)peptide constructs |
| 03/04/2004 | WO2003065871A3 Methods and compositions for treating hematological disorders |
| 03/04/2004 | WO2003055980A3 Il-17 like molecules and uses thereof |
| 03/04/2004 | WO2003055905A3 Proteins of non typable haemophilus influenzae |
| 03/04/2004 | WO2003055442A3 Treatment of sepsis by low dose administration of tissue factor pathway inhibitor (tfpi) |